are supported by Fellowships from the National Breast Cancer Foundation (NBCF) Australia. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The Australian Breast Cancer Family Study (ABCFS) would like to thank Maggie ...
This work is further supported by a research grant from The National Breast Cancer Foundation (NBCF) of Australia (IIRS-19-106) and the Petre Foundation. A.S. is a Senior Research Fellow of the National Health and Medical Research Council of Australia. Funding Open access funding provided ...
Breast CancerDiscusses highlights of the Combined Clinical Staff Conference on breast cancer at the National Institutes of Health. Variation in breast cancer mortality rate; Prevention of breast cancer; Hormonal control of breast cancer.Annals of Internal Medicine...
Constitutive expression of CCL2 by the mouse mammary epithelium induces a state of low level chronic inflammation that increases stromal density and elevates cancer risk. We propose that CCL2-driven inflammation contributes to the increased risk of breast cancer observed in women with high mammographic...
Human epidermal growth factor receptor-2 (HER2)-targeted therapies prolong survival in HER2-positive breast cancer patients. Benefit stems primarily from improved control of systemic disease, but up to 50% of patients progress to incurable brain metastas
ArticleOptimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging Author links open overlay panelAlessia Floerchinger 1 9, Kendelle J. Murphy 1 9, Sharissa L. Latham 1, Sean C. Warren 1, Andrew T. McCulloch 1, Young-Kyung ...
Breast cancer development and metastasis is a multistep process, often caused by dysfunction of several regulatory features those keep cells in check [3]. Continents such as North America, Western Europe and Australia have been reported to have the highest incidence rates. Nevertheless, it is ...
In the current study, we describe the fine-scale mapping of the 2q35 breast cancer susceptibility locus using 1,560 genotyped and imputed single nucleotide polymorphisms (SNPs) in 101,943 subjects from 50 case-control studies. The strongest candidate for causality, SNP rs4442975, flanks a ...
(NHMRC), the National Breast Cancer Foundation (NBCF), Cancer Australia and the National Institute of Health (United States) for their contributions to this research, and the many families who contribute to kConFab. We wish to thank the FACS core facility staff R. Rossi, V. Milovac and S...
"Our ongoing partnership with NBCF is a cornerstone of LILYSILK's mission to make a tangible difference in the community," saidDavid Wang, CEO of LILYSILK. "The Caring Collection transcends mere symbolism. It's a tangible pillar of support to those battl...